SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Chase ES, Hoffman RA. Resolution of dimly fluorescent particles: A practical measure of fluorescence sensitivity. Cytometry 1998; 33: 267279.
  • 2
    Maecker HT, Frey T, Nomura LE, Trotter J. Selecting fluorochrome conjugates for maximum sensitivity. Cytometry A 2004; 62: 169173.
  • 3
    Roederer M. Spectral compensation for flow cytometry: Visualization artifacts, limitations, and caveats. Cytometry 2001; 45: 194205.
  • 4
    Maecker HT, Rinfret A, D'Souza P, Darden J, Roig E, Landry C, Hayes P, Birungi J, Anzala O, Garcia M, Harari A, Frank I, Baydo R, Baker M, Hol-brook J, Ottinger J, Lamoreaux L, Epling CL, Sinclair E, Suni MA, Punt K, Calarota S, El-Bahi S, Alter G, Maila H, Kuta E, Cox J, Gray C, Altfeld M, Nougarede N, Boyer J, Tussey L, Tobery T, Bredt B, Roederer M, Koup R, Maino VC, Weinhold K, Pantaleo G, Gilmour J, Horton H, Sekaly RP. Standardization of cytokine flow cytometry assays. BMC Immunol 2005; 6: 13.
  • 5
    Currier JR, Kuta EG, Turk E, Earhart LB, Loomis-Price L, Janetzki S, Ferrari G, Birx DL, Cox JH. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods 2002; 260: 157172.
  • 6
    Ghanekar SA, Maecker HT, Maino VC. Immune monitoring using cytokine flow cytometry. In: RoseNR, editor. Manual of Clinical Laboratory Immunology, 7th ed. Washington, DC: ASM Press; 2005; 353360.